MOPE Clinic Highlights Blood Pressure Monitoring as Testosterone Safety Information Evolves

Mope clinic provides educational context on testosterone, blood pressure, cardiovascular health & patients can discuss with their healthcare providers.

METAIRIE, LA, UNITED STATES, October 5, 2026 /EINPresswire.com/ -- MOPE Clinic Highlights Blood Pressure Monitoring as Testosterone Safety Information Evolves

As testosterone therapy continues to receive attention among men seeking answers about energy, body composition, sexual health and other symptoms, MOPE Clinic is encouraging a broader conversation about an issue that can sometimes be overlooked: blood pressure and overall cardiovascular health.

The topic has become increasingly relevant as the U.S. Food and Drug Administration has updated safety information for testosterone products based on newer cardiovascular and blood pressure data.

In February 2025, the FDA announced class-wide labeling changes for testosterone products following its review of findings from the TRAVERSE cardiovascular outcomes trial and required postmarket ambulatory blood pressure monitoring studies. The agency removed boxed-warning language concerning an increased risk of adverse cardiovascular outcomes while also requiring testosterone products to include information about increased blood pressure. For patients, those changes can seem contradictory at first. They are better understood as an example of how medical evidence evolves.

Testosterone therapy should not be characterized as universally dangerous to cardiovascular health, but the newer evidence does not mean blood pressure and other health risks can be ignored. Individual medical history, symptoms, laboratory findings, cardiovascular risk and appropriate monitoring remain important.

UNDERSTANDING LOW TESTOSTERONE AND HIGH BLOOD PRESSURE

Low testosterone and high blood pressure can occur in the same person, but their presence together does not prove that one condition caused the other. Testosterone levels can be influenced by age, body composition, sleep, illness, medications and metabolic health. Blood pressure can be affected by genetics, body weight, kidney function, cardiovascular health, physical activity, diet, medications, sleep and other factors.

Several of those factors overlap.

For example, excess body weight and metabolic concerns may be associated with both cardiovascular risk and changes in hormone health. Sleep problems can also complicate the picture. This is why symptoms should be considered within the context of the patient's overall health rather than automatically attributed to testosterone. Fatigue is a good example. A man experiencing persistent fatigue may wonder whether low testosterone is responsible. However, fatigue is nonspecific and can occur with inadequate sleep, sleep disorders, medication effects, metabolic conditions and numerous other health concerns.

The same principle applies to changes in sexual function, mood, exercise tolerance and body composition. Symptoms can provide important clues, but they do not independently establish a diagnosis.

WHY SLEEP DESERVES ATTENTION

Sleep is particularly relevant when discussing testosterone and cardiovascular health. Obstructive sleep apnea can be associated with high blood pressure and other cardiovascular concerns. Symptoms can include loud snoring, witnessed pauses in breathing during sleep, morning headaches and excessive daytime sleepiness. Some of those symptoms may overlap with complaints that lead men to seek a hormone evaluation in the first place. That does not mean everyone with fatigue or low testosterone has sleep apnea. It does mean that significant sleep symptoms should be discussed with a healthcare professional instead of being automatically attributed to hormone levels. A comprehensive conversation may therefore include more than testosterone results.

WHAT THE TRAVERSE TRIAL ADDED TO THE CONVERSATION

The TRAVERSE trial was designed to examine cardiovascular safety in men with hypogonadism who had preexisting cardiovascular disease or an increased risk of cardiovascular disease. The study included 5,246 men between ages 45 and 80 who had symptoms of hypogonadism and two fasting testosterone measurements below 300 ng/dL. Participants were randomly assigned to receive testosterone gel or placebo. For the study's primary cardiovascular endpoint, testosterone therapy was found to be noninferior to placebo for major adverse cardiovascular events in the population studied. That finding contributed to the FDA's subsequent decision to remove previous boxed-warning language regarding increased risk of adverse cardiovascular outcomes from testosterone product labeling.

However, the findings should not be interpreted as evidence that testosterone therapy is appropriate or risk-free for every patient. Researchers also reported differences in certain adverse events between the study groups. The results therefore support a more nuanced discussion about testosterone therapy rather than a blanket conclusion about safety. Individual risk factors still matter.

WHY BLOOD PRESSURE REMAINS IMPORTANT

Separate from the TRAVERSE cardiovascular outcomes trial, the FDA required manufacturers of testosterone products to conduct ambulatory blood pressure monitoring studies. Those studies demonstrated increased blood pressure across testosterone products to varying degrees.

As a result, the FDA required labeling changes concerning increased blood pressure. Blood pressure therefore remains an important consideration when testosterone therapy is being evaluated or monitored.

A single elevated blood pressure reading does not necessarily establish chronic hypertension. Blood pressure can vary based on activity, stress, caffeine, illness and other factors. Likewise, a single normal reading does not necessarily describe a person's cardiovascular health over time. Patterns and clinical context matter. Patients who already have hypertension or cardiovascular concerns may need those conditions considered as part of an individualized testosterone evaluation.

LOOKING BEYOND ONE TESTOSTERONE NUMBER

Testosterone care should involve more than trying to increase a laboratory value. Symptoms, medical history and appropriate laboratory testing all provide context. “Testosterone care should look beyond one laboratory number. Blood pressure, symptoms, medical history and appropriate follow-up all help provide a more complete clinical picture,” said Chris Rue, FNP-C, MOPE Clinic.

For example, a testosterone result needs to be interpreted within the circumstances in which it was obtained and alongside the patient's symptoms and clinical history. Likewise, someone receiving testosterone therapy may require follow-up that considers more than testosterone itself. Depending on the individual and treatment, clinicians may evaluate blood pressure and laboratory values such as hemoglobin and hematocrit. Testosterone can stimulate red blood cell production in some patients. Monitoring can help a clinician identify changes that deserve additional evaluation. The appropriate monitoring plan depends on the individual patient.

PRACTICAL STEPS PATIENTS CAN TAKE BEFORE AN APPOINTMENT

Patients do not need to diagnose themselves to become better prepared for a medical appointment. Several simple organizational steps may help provide useful information to a healthcare professional.

KEEP AN ACCURATE MEDICATION LIST

Write down prescription medications, over-the-counter medications and supplements. Include the dose when known. This information can help a clinician understand factors that might affect symptoms, blood pressure or laboratory findings. Patients should not discontinue prescribed medications simply because they believe a medication may be contributing to a symptom. Medication changes should be discussed with the prescribing healthcare professional.

ORGANIZE PREVIOUS LABORATORY RESULTS

Patients who have recent laboratory testing from another healthcare provider can bring those results to their appointment when available. Previous results may help a clinician understand changes over time.

WRITE DOWN SYMPTOMS BEFORE THE VISIT

Instead of simply writing “tired,” consider documenting when the fatigue began, whether it occurs every day, whether sleep is restorative and whether other symptoms developed around the same time. This does not diagnose the cause. It simply provides more useful information for the medical conversation.

PAY ATTENTION TO SLEEP QUALITY

Patients may want to note loud snoring, frequent waking, witnessed pauses in breathing, morning headaches or significant daytime sleepiness. Those observations can be discussed with a healthcare professional if they are occurring.

KEEP BLOOD PRESSURE INFORMATION ORGANIZED WHEN APPROPRIATE

Patients who have been instructed by a healthcare professional to monitor blood pressure at home can record their readings, dates and times. Rather than reacting to one number, a record may help the treating clinician understand the broader pattern. Home monitoring should not be used as a substitute for medical care or as a reason to independently change prescribed medications.

BRING QUESTIONS TO THE APPOINTMENT

Writing down questions beforehand can make it easier to remember them during a medical visit. Questions might include how existing blood pressure concerns affect a testosterone evaluation, what follow-up may be appropriate and which changes should prompt a call to the treating clinician.

WHAT PATIENTS SHOULD NOT DO ON THEIR OWN

Access to health information online has made it easier for patients to learn about testosterone, but it has also created opportunities for confusion. Treatment protocols shared on social media, message boards or videos may not account for an individual's health history.

Patients should not increase testosterone because another person's dose is higher. They should not decrease or discontinue prescribed treatment solely because someone online reported a side effect. They also should not alter blood pressure medication based on information found online. A meaningful change in blood pressure, symptoms or laboratory findings should be discussed with the healthcare professional managing the relevant treatment.

FREQUENTLY ASKED QUESTIONS

Can low testosterone cause high blood pressure?

Low testosterone and high blood pressure may occur together, but that does not prove that low testosterone directly caused hypertension. The two can share contributing factors, including age, body composition, sleep and metabolic health. An individualized medical evaluation can help put the findings into context.

Can testosterone replacement therapy increase blood pressure?

Testosterone therapy can increase blood pressure in some patients. FDA labeling includes blood pressure information based on required ambulatory blood pressure monitoring studies. The degree of change and individual clinical significance can vary.

Does testosterone therapy automatically increase the risk of a heart attack or stroke?

Current evidence is more nuanced. In the TRAVERSE trial, testosterone therapy was noninferior to placebo for major adverse cardiovascular events among the men included in the study. Those results do not establish that testosterone is risk-free or appropriate for every patient.

Why did the FDA change the testosterone cardiovascular warning?

The FDA reviewed results from the TRAVERSE trial and subsequently removed boxed-warning language related to an increased risk of adverse cardiovascular outcomes. At the same time, evidence from ambulatory blood pressure monitoring studies resulted in class-wide blood pressure labeling changes.

Why would the FDA remove one warning while adding blood pressure information?

The two decisions address different evidence. The cardiovascular outcomes data from TRAVERSE informed the previous cardiovascular warning, while separate studies provided information about blood pressure changes. Medical safety information can become more specific as additional evidence becomes available.

Can someone with high blood pressure receive testosterone therapy?

A diagnosis of hypertension does not by itself answer whether testosterone therapy is appropriate for an individual. Blood pressure control, cardiovascular history, symptoms, laboratory findings, medications and other health considerations may need to be evaluated by a healthcare professional.

Should blood pressure be checked during testosterone therapy?

Blood pressure can be an important consideration during testosterone treatment. The appropriate monitoring schedule depends on the individual, treatment and healthcare professional's clinical judgment.

What should someone do if blood pressure increases after beginning testosterone?

A meaningful change should be discussed with the clinician managing treatment. Patients should not independently increase, decrease or stop testosterone or prescribed blood pressure medication based solely on information found online.

Is fatigue always caused by low testosterone?

No. Fatigue can have many potential causes, including poor sleep, sleep disorders, medication effects and other medical conditions. Symptoms alone cannot determine whether testosterone is low or whether testosterone therapy is appropriate.

Does one low testosterone result mean someone needs TRT?

A single result alone does not determine whether testosterone therapy is appropriate. Diagnosis and treatment decisions depend on symptoms, appropriate laboratory evaluation, medical history and individual clinical circumstances.

Why might hematocrit be monitored during TRT?

Testosterone can stimulate red blood cell production in some patients. Hematocrit provides information about the proportion of blood made up of red blood cells. A clinician can determine whether and how frequently it should be monitored.

Can losing weight or exercising replace a testosterone evaluation?

Lifestyle habits and medical evaluation address different questions. Physical activity, nutrition and healthy body composition can support overall health, but symptoms that may be associated with testosterone deficiency still require appropriate medical evaluation when clinically indicated.

Can sleep problems affect a hormone evaluation?

Sleep and hormone health can overlap. Significant sleep problems may also produce symptoms similar to those associated with low testosterone. Patients should mention persistent sleep concerns during an evaluation.

Is home blood pressure monitoring enough to diagnose hypertension?

Home readings can provide useful information, but patients should work with a healthcare professional to interpret them and determine whether additional evaluation is appropriate. Home measurements should not be used to self-diagnose or independently change medication.

Are all testosterone treatments the same?

No. Testosterone is available in different formulations, and product-specific safety information can differ. Treatment selection and monitoring should be individualized by an appropriately licensed healthcare professional.

QUESTIONS PATIENTS MAY WANT TO ASK THEIR HEALTHCARE PROVIDER

An informed medical conversation can begin with simple questions.

Patients considering testosterone therapy may want to discuss how testosterone deficiency is evaluated, whether another health condition could be contributing to symptoms, and whether their blood pressure or cardiovascular history affects treatment considerations.

They may also want to ask what laboratory values could require monitoring, which changes should be reported between appointments, whether sleep quality could be contributing to symptoms, how treatment response will be evaluated and which potential risks are relevant to their personal medical history.

These questions are not a substitute for clinical evaluation. They can help patients participate more actively in conversations about their care.

LOCAL MEN'S HEALTH EDUCATION IN GREATER NEW ORLEANS

Men in Metairie, New Orleans and surrounding South Louisiana communities have access to a growing amount of information about testosterone through social media, advertising and online health discussions. The amount of information can make it difficult to distinguish general education from advice appropriate for an individual patient.

MOPE Clinic encourages patients to view hormone health as one component of overall health rather than treating testosterone as an isolated number. Blood pressure, cardiovascular history, sleep, symptoms, body composition, medications and laboratory findings can all provide useful context.

The evolving FDA safety information reinforces that approach. New evidence can refine the understanding of treatment risks without eliminating the need for individualized evaluation and appropriate follow-up.

MOPE Clinic has published additional educational information about low testosterone and high blood pressure, including questions patients can discuss with their healthcare providers.

ABOUT MOPE CLINIC

MOPE Clinic is a physical clinic located in Metairie, Louisiana, serving Greater New Orleans and South Louisiana. Concierge visits are available by appointment. Chris Rue, FNP-C, provides individualized clinical care, including hormone-related services, based on patient history, symptoms, appropriate clinical information and individual needs.

For information about MOPE Clinic, call 504-265-5491 or email info@mopeclinic.com.

This press release provides general educational information. It is not intended to diagnose testosterone deficiency, hypertension, cardiovascular disease or another medical condition; recommend testosterone therapy; provide individualized treatment instructions; or replace care from an appropriately licensed healthcare professional.

Gwen M.
Designs For You
email us here
Visit us on social media:
Facebook